$8.92 0.22 (+2.53%)
11/25/2009 4:00 PM

Nektar Therapeutics (NKTR)

CAPS Rating: 3 out of 5

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

Featured Broker Partners